Genetic Engineering News: Breaking Genetic Engineering News, Comments and Articles.

09:24 EST 21st December 2014 | BioPortfolio

Genetic Engineering NewsRSS

Read the latest Genetic Engineering News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Genetic Engineering.

Search or Follow Our Genetic Engineering News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Genetic Engineering News.

Showing "genetic engineering genetics" News Articles 1 to 25 of 7,600+

Saturday 20th December 2014

Concept Plus, LLC. Named One of Washington Technology’s Fast 50

Fairfax, Virginia (PRWEB) December 21, 2014 Concept Plus, LLC. a SDB and 8(a) certified IT consulting, management and engineering firm headquartered in Fairfax, VA., today announced it has been recognized by Washington Technology as a part of it...

Ibuprofen could be an anti-aging medicine

Ibuprofen, a common over-the-counter drug used to relieve pain and fever, could hold the keys to a longer healthier life, according to a study by researchers at the Buck Institute for Research on Aging. Publishing in PLoS Genetics on December 18th, ...

Scientists use "molecular GPS" to study enzymes

Chuck Bednar for redOrbit.com - Your Universe Online The same device that helps keep you from getting lost on long trips has inspired scientists to track the metal ions in enzymes essential for metabolism and the synthesis of biological products, according to research published in the latest edition of the journal Angewandte Chemie. Professor Dr. Olav Schiemann of the Institute for Physical and ...

Friday 19th December 2014

Myriad II: Another Blow to the Patenting of Biotech Innovation

On December 17 the Federal Circuit issued a unanimous decision invalidating product and method claims relating to BRCA genetic diagnostic testingfor lack of patent eligibility. The decision, formally titled In re BRCA1- & BRCA2- Based Hereditary...

Genetic Analysis Reveals the U.S. is Truly a Melting Pot

The United States is often described as a cultural melting pot. The degree to which that's true socially can be debated – and, at least as regards to race, it has been debated lots lately. But another way to look at that question could be to exam...

FDA Approves AstraZeneca Ovarian Cancer Drug

The U.S. Food and Drug Administration approved the first drug to treat cases of ovarian cancer linked to specific genetic mutations.

Roche down on Phase III setbacks

Roche (SIX:ROG; OTCQX:RHHBY) fell CHF18.30 to CHF270.40 on Friday after reporting disappointing data from a Phase III trial of breast cancer drug Kadcyla ado-trastuzumab emtansine and discontinuing a Phase III study of gantenerumab

FDA approves AstraZeneca's Lynparza

FDA granted accelerated approval to Lynparza olaparib from AstraZeneca plc (LSE:AZN; NYSE:AZN) as monotherapy in patients with deleterious or suspected deleterious germline BRCA mutated advanced ovarian cancer, as detected by an FDA-approved test, wh...

FDA Approves Myriad's PARP Inhibitor for Ovarian Cancer

Myriad Genetics, Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) for BRACAnalysis CDx to be used as the only companion diagnostic in conjunction with AstraZeneca’s drug Lynparza (olaparib). Lynparza is the first poly ADP-ribose polymerase (PARP) inhibitor for patients with germline mutations in BRCA1/2 advanced ovarian cancer who have had three or m...

‘Tis the season to be shameless

I received two nice holiday gifties: My recent essay on race, genetics, and the Nicholas Wade affair heads up Nature’s top 10 list of Books & Arts pieces for 2014. <blows […]

Crohn's, Colitis May Have Genetic Underpinnings, Study Finds

FRIDAY, Dec. 19, 2014 -- The intestinal bacteria that cause inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, may be inherited, researchers report. The findings, published recently in the journal Genome Medicine,...

Cure Duchenne to Sponsor Duplication Research for Duchenne Muscular Dystrophy with Dr. Kevin Flanigan from Nationwide Children’s Hospital

CureDuchenne, a national nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, announced today that they are sponsoring a $710,000 research project with

Ibuprofen leads to extended lifespan, study shows

COLLEGE STATION -- Regular doses of ibuprofen extended the lifespan of multiple species, according to research published in Public Library of Science-Genetics. "We first used baker's yeast, which is an established aging model, and noticed that the ye...

Roche buys antibody engineering firm led by ex-Serono team

Dutalys's technology is fully human, whereas conventional bispecific MAbs are bio-engineered artificial proteins composed of fragments of two different MAbs. This artificial engineering has been associated with poor stability and increased risk of...

Programme for genetic diagnosis of rare diseases proves feasible for routine clinical practice

A nationwide programme to genetically diagnose rare diseases is feasible for use in routine NHS patient care, results from the first 1000 families analysed have shown.1Use of genomic sequencing to...

Vital Connect Announces Additions to Executive Team

Chief architect steps into COO role, new executive hires support global growth Vital Connect, Inc. has announced several new additions to its executive team, including a new Chief Operating Officer. Company growth in Europe and developing partnerships in key markets fueled the expansion of the Vital Connect leadership team. Formerly Chi...

LYNPARZA(TM) Approved By The US Food and Drug Administration For The Treatment Of Advanced Ovarian Cancer In Patients With Germline BRCA-mutations

WILMINGTON, Del., Dec. 19, 2014 /PRNewswire/ -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved LYNPARZA™ (olaparib) capsules. LYNPARZA is the first poly ADP-ribose polymerase (PARP) inhibitor indicated as monotherapy in patients with deleterious or suspected deleterious germline BRCA-mutated (as detected by an FDA-approved test) advanced ovarian ...

LYNPARZA™ Approved By The US Food and Drug Administration For The Treatment Of Advanced Ovarian Cancer In Patients With Germline BRCA-mutations

WILMINGTON, Del., Dec. 19, 2014 /PRNewswire/ -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved LYNPARZA™ (olaparib) capsules. LYNPARZA is the first poly ADP-ribose polymerase (PARP) inhibitor indicated as monotherapy in patients with deleterious or suspected deleterious germline BRCA-mutated (as detected by an FDA-approved test) advanced ovarian ...

Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation

IRVINE, Calif., Dec. 19, 2014 /PRNewswire/ -- Newport Corporation (NASDAQ: NEWP) announced today that Siddhartha Kadia, Ph.D. has joined the company's Board of Directors.  Dr. Kadia is President and Chief Executive Officer and a director of Evans Analytical Group, a leading global provider of high-precision laboratory testing, evaluation and analytical services to companies in a wide ran...

The state of shale

PITTSBURGH--University of Pittsburgh researchers have shared their findings from three studies related to shale gas in a recent special issue of the journal Energy Technology, edited by Götz Veser, the Nickolas A. DeCecco Professor of Chemical a...

Georgia Bio Deals of the Year Spotlight Financings, Acquisitions and Collaboration

Georgia Bio announced its 2015 Deals of the Year for pharmaceutical, biotechnology, healthcare IT and medical device companies in three categories – private financing, acquisitions and public/private collaboration – reflecting a broad range of activity. The annual Deal of the Year awards recognize transactions by life sciences companies in Georgia such...

Who’s Your Favorite Leading Lady in Technology? Entertainment Industries Council, NCWIT and Google Want to Know!

Nominations Are Being Accepted Now for SET Award for Portrayal of a Female in Technology, Presented by EIC, NCWIT & Google on YouTube Los Angeles, CA (PRWEB) December 19, 2014 The Entertainment Industries Council (EIC), NCWIT and Google are accepting nominations for the SET Award for Portrayal of a Female in Technology. The special SET Award honoring Science, Engineering and Technology portra...

SMI Eye Tracking Glasses Set the Industry Standard for Professional Research and Training

SMI’s wearable eye tracker is the most recognized eye tracking tool available for professional use in market research, human factors, professional training and cognitive science SensoMotoric Instruments (SMI), has completed the integration of the company’s renowned eye tracking technology for use in slim and lightweight eyeglasses. Already c...

Alnylam Announces Planned Departure of Chief Business Officer, Laurence Reid, Ph.D.

Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that Laurence Reid, Ph.D., the company’s Chief Business Officer, plans to resign from the company, effective December 31, 2014. Dr. Reid will be joining Third Rock Ventures (TRV) as an Entrepreneur-in-Residence, and is expected to become a Chief Executive ...

Tekmira says chief technical officer resigns

Tekmira Pharamceuticals (TSE:TKM) (NASDAQ:TKMR) said that its chief technical officer, Dr. Ian MacLachlan, will resign from the company at the end of the month.  Shares dropped 1.7 percent to C$15.64 on Friday. The company said Dr. MacLachlan ha...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks